Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Conditions: Multiple Myeloma; Extramedullary Plasmacytoma Interventions: Drug: Daratumumab; Drug: Bortezomib; Drug: Cyclophosphamide; Drug: Dexamethasone Sponsors: European Myeloma Network; Janssen, LP Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials